The FDA approved Moderna’s Biologics License Application (BLA) for its mRNA-based flu vaccine, mRNA-1010 (mFlusiva; Moderna), ...

Katherine Wilemon, Family Heart Foundation, described the biggest unmet need when it comes to public awareness of Lp(a) and ...

Accelerated approval positions RP1 plus nivolumab for advanced melanoma after progression on prior anti–PD-1 therapy, following two CRLs and a 10–3 advisory committee recommendation. In IGNYTE (n=140) ...

Health plans can use routine pharmacy claims to identify members at high risk for early discontinuation of glucagon-like peptide-1 receptor agonists and deliver targeted, equity-conscious adherence ...

Bruton tyrosine kinase (BTK) inhibitors have become a mainstay of treatment for relapsed or refractory (R/R) mantle cell ...

UPMC and Birth Root Community Doula describe a 4-year partnership addressing food insecurity, housing, and maternal health ...

Steven D. Nathan, MD, discusses inhaled treprostinil and why inhaled therapies could mark the next frontier in idiopathic pulmonary fibrosis (IPF) care. “I think this further opens the door for other ...

Anosheh Afghahi, MD, discusses biomarker testing, trial matching technology, and community-academic partnerships to improve ...

Rising summer temperatures and prolonged UV exposure can accelerate the breakdown of larger plastics into these microscopic particles, increasing opportunities for human exposure, ...

Eligibility definitions differ across reports, particularly whether prior failure on highest approved antiobesity dose is required versus documenting discussion of all standard treatments. A one-off ...

Prior authorization, coverage limits, and affordability screening increasingly determine when CAR T or bispecifics are ...

Senate confirmation restores a durable leadership structure for CDC accountability after protracted reliance on interim arrangements and questions under the Federal Vacancies Reform Act. Contentious ...